| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/07/1993 | WO1993000102A1 Apc polypeptides and anti-peptide antibodies, diagnostic methods and systems for inhibitng apc, and therapeutic methods |
| 01/07/1993 | WO1993000049A1 Osteogenic factor |
| 01/07/1993 | EP0521767A1 Production process of recombinant proteins and used host cells |
| 01/07/1993 | EP0521586A1 FSH and other recombinant hormones |
| 01/07/1993 | EP0521427A1 Method for identifying non-essential genes of the human cytomegalovirus genome and for screening for inhibitors of human cytomegalovirus |
| 01/07/1993 | EP0521408A1 Glycopeptide antibiotics derivated from balhimycin |
| 01/07/1993 | EP0521348A1 Chimeric antibody with specificity for hepatitis B virus pre-S2 surface antigen and cell line producing same |
| 01/07/1993 | EP0521318A2 Hepatitis C diagnostics and vaccines |
| 01/07/1993 | EP0521240A2 Novel bacteriocin from lactococcus lactis subspecies lactis |
| 01/07/1993 | EP0521220A1 Recombinant immunogenic actinomycetale |
| 01/07/1993 | EP0521156A1 Dna coding for granulocytic colony stimulating factor receptor |
| 01/07/1993 | EP0521094A1 USE OF A COLEOPTERAN ACTIVE -i(BACILLUS THURINGIENSIS) FOR CONTROLLING THE CEREAL LEAF BEETLE -i(OULEMA MELANOPA L. (LEMA MELANOPA (L.))). |
| 01/07/1993 | EP0484440A4 Efficient directional genetic cloning system |
| 01/07/1993 | DE4209215A1 Hcv peptidantigene und verfahren zur bestimmung von hcv HCV peptide antigens, and methods for the determination of HCV |
| 01/07/1993 | DE4122402A1 Verwendung von interleukin 10 zur herstellung von arzneimitteln mit tumorhemmender wirksamkeit Use of interleukin 10 for the manufacture of medicaments having tumor-inhibiting efficacy |
| 01/07/1993 | DE4121431A1 Peptide(s) for hepatitis-C virus detection |
| 01/07/1993 | CA2580812A1 Ctla4 receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | CA2112492A1 A differentiated megakaryocyte line producing novel megakaryocyte differentiation factors |
| 01/07/1993 | CA2112226A1 Purification of recombinant apolipoprotein e from bacteria |
| 01/07/1993 | CA2111870A1 Calpain-inhibiting peptide analogs of the kininogen heavy chain |
| 01/07/1993 | CA2111683A1 Capsid forming and cystein modified chimaeric ms2-coat protein |
| 01/07/1993 | CA2093790A1 Osteogenic factor |
| 01/06/1993 | CN1067680A Hepatitis b virus surface proteins with reduced host carbohydrate content |
| 01/06/1993 | CN1067679A Recombinant dha-derived cholera toxin subunit analogs |
| 01/06/1993 | CN1067678A Recombinant b oligomer of pertussis toxin |
| 01/06/1993 | CA2073085A1 Method for identifying non-essential genes of the human cytomegalovirus genome and for screening inhibitors of human cytomegalovirus |
| 01/05/1993 | WO1993001210A2 Hcv peptide-antigens and a method of testing for the hepatitis c virus (hcv) |
| 01/05/1993 | US5177308 Genetic engineering |
| 01/05/1993 | US5177307 Compositions and methods for modulation of endogenous cytokinin levels |
| 01/05/1993 | US5177197 Isolated nucleotide sequence expressing human transforming growth factor-β1-binding protein |
| 01/05/1993 | US5177194 Process for purifying immune serum globulins |
| 01/05/1993 | US5177193 In vivo half-life, genetic engineering |
| 01/05/1993 | US5177191 Polyethylene glycol precipitation, virus deactivation |
| 01/05/1993 | US5177190 Purified C5a receptor from human polymorphonuclear leukocytes |
| 01/05/1993 | US5177189 Polypeptide analogs of Apolipoprotein E |
| 01/05/1993 | US5177188 Polypeptides |
| 01/05/1993 | US5177060 Anti-inflammatory peptides and treatment to inhibit vascular leakage in injured tissues |
| 01/05/1993 | US5177058 Insulin derivatives |
| 01/05/1993 | US5177020 Method for the immunological determination of heparan sulfate-proteoglycan and process for the preparation and purification of heparan sulfate-proteoglycan suitable for this purpose from tissues containing basal membrane |
| 01/05/1993 | US5177014 Immunology |
| 01/05/1993 | US5177011 Plant elongation factor promoters, coding sequences and uses |
| 01/05/1993 | US5177002 Glycosidases |
| 01/05/1993 | US5177001 In vitro enzymatic conversion of glycosylated mammalian vitamin D-binding protein to a potent macrophage activating factor |
| 01/05/1993 | US5176995 Detection of viruses by amplification and hybridization |
| 01/05/1993 | US5176994 Immunoassay |
| 01/05/1993 | US5176937 Plant extract of Curculigo latifolia fruit, carbon dioxide gas or carbonate or cationic exchange resin |
| 01/05/1993 | US5176910 Treponema hyodysenteriae hemolysin and uses therefor |
| 01/05/1993 | CA2089576A1 Hcv peptide antigens and methods for the determination of hcv |
| 01/05/1993 | CA1312278C Process for the preparation of factor viii:c-deficient plasma, and a deficient plasma obtained in this way |
| 01/02/1993 | CA2072834A1 Ketone derivatives |
| 01/02/1993 | CA2072395A1 Bicyclic endothelin analogues |
| 01/02/1993 | CA2072390A1 Endothelin analogues with alpha-amine substitution at residue 20 |
| 12/30/1992 | EP0520834A2 Pharmaceutical composition for treating an immune system disorder comprising PP14 or antibodies against PP14 |
| 12/30/1992 | EP0520753A1 Recombinant fowlpox vaccine for protection against Marek's disease |
| 12/30/1992 | EP0520502A2 Anti-Hirudin polyclonal antibodies and their use for the identification, immunopurification and quantitative determination of hirudin |
| 12/30/1992 | EP0520427A1 Cyclopropenone derivatives |
| 12/30/1992 | EP0520158A1 Truncated forms of the hepatocyte growth factor (HGF) receptor |
| 12/30/1992 | EP0520026A1 Megakaryocytic in vitro cell line |
| 12/30/1992 | EP0519986A1 Synthetic polypeptides |
| 12/30/1992 | EP0519953A1 Acyl phosphate esters and modification of proteins therewith. |
| 12/30/1992 | EP0208785B1 Fibrinophilic urokinase complex and process for its preparation |
| 12/30/1992 | CN1067382A Human papilloma viral peptide expression and use in immunogenic compositions |
| 12/30/1992 | CA2072725A1 Glycopeptides, a process for their preparation and their use |
| 12/29/1992 | US5175385 Virus-resistant transgenic mice |
| 12/29/1992 | US5175384 For model systems to study aids |
| 12/29/1992 | US5175383 Animal model for benign prostatic disease |
| 12/29/1992 | US5175272 DNA sequences with increased expression of HBcAg |
| 12/29/1992 | US5175268 DNA encoding recombinant human lymphotoxin |
| 12/29/1992 | US5175255 Methods for purification of platelet-derived growth factor |
| 12/29/1992 | US5175253 Serpin-enzyme complex receptor binding pentapetides |
| 12/29/1992 | US5175252 Cloned gene encoding for bacteriocin from pediococcus acidilactici |
| 12/29/1992 | US5175251 Antitumor agents |
| 12/29/1992 | US5175148 Synthetic peptide; immunocontraceptive agent, diagnosis of autoimmune infertility |
| 12/29/1992 | US5175147 Acid-resistant fgf composition and method of treating ulcerating diseases of the gastrointestinal tract |
| 12/29/1992 | US5175146 Synthetic calcitonin peptides |
| 12/29/1992 | US5175113 Modified β2 -microglobulin |
| 12/29/1992 | US5175105 Process for the production of urokinase using saccharomyes cerevisiae |
| 12/29/1992 | US5175102 Modification of plant viruses or their effects |
| 12/29/1992 | US5175099 Retrovirus-mediated secretion of recombinant products |
| 12/29/1992 | US5175098 Expression and diagnostic use of gag encoded peptides which are immunologically reactive with antibodies to HIV |
| 12/29/1992 | US5175097 Genetic engineering |
| 12/29/1992 | US5175096 Dna encoding a fibronectin binding protein as well as its preparation |
| 12/29/1992 | US5175095 Ovary-tissue transcriptional factors |
| 12/29/1992 | US5175094 Increased expression of HBcAg |
| 12/29/1992 | US5175085 Methods and compositions for diagnosing autoimmune insulin dependent diabetes mellitus |
| 12/29/1992 | US5174993 Immunology |
| 12/29/1992 | US5174986 Method for determining oncogenic potential of a chemical compound |
| 12/29/1992 | CA2064544A1 Immune cell proliferation inhibitors |
| 12/29/1992 | CA1312031C Process for the purification of serum albumin |
| 12/29/1992 | CA1312029C Method for increasing gene expression |
| 12/29/1992 | CA1312026C Plasmid vectors for efficient expression of genes in e. coli |
| 12/29/1992 | CA1312025C Monoclonal antibodies and antigen for human non-small cell lung carcinomaand certain other human carcinomas |
| 12/29/1992 | CA1312009C Extra pure semi-synthetic blood substitute |
| 12/28/1992 | CA2072246A1 Ccv vaccine |
| 12/24/1992 | DE4120345A1 Protein fragments obtd. from middle region of Borrelia burgdorferi - for quantitative detection of B. burgdorferi antibodies in serum without false positive results |
| 12/24/1992 | DE4120281A1 Peptide(s) for hepatitis-C virus detection |
| 12/23/1992 | WO1992022667A1 Analogs of glycoprotein hormone receptors which bind choriogonadotrophins, leutrophins, and follitrophins and methods for preparing and using same |
| 12/23/1992 | WO1992022665A1 Production and recovery of recombinant neurotrophins |
| 12/23/1992 | WO1992022664A1 Chemotactic factor |
| 12/23/1992 | WO1992022658A1 Recombinant immunogenic actinomycetale |